Target intelligence / Profile preview

B7 Proteins: CD80 (B7-1) and CD86 (B7-2) (B7)

Target
B7
Molecular classification
Type I transmembrane glycoprotein, Immunoglobulin superfamily, Receptor
01

Overview

CD80 (B7-1) and CD86 (B7-2) are type I transmembrane glycoproteins belonging to the immunoglobulin superfamily, expressed primarily on antigen-presenting cells (APCs). They provide costimulatory signals to T cells through interaction with CD28, leading to T cell activation. They also interact with CTLA-4, delivering inhibitory signals that regulate T cell responses. CD80 and CD86 play a crucial role in modulating immune responses and are targets for immunotherapy.

Other names
CD80B7-1CD86B7-2
02

Mechanism of action

CD80 and CD86 bind to CD28 on T cells to provide costimulatory signals, promoting T cell activation and proliferation. They also bind to CTLA-4, delivering inhibitory signals that dampen T cell responses.

03

Biological functions

T-cell costimulationT-cell activationT-cell proliferationCytokine productionImmune response regulationImmune checkpoint
04

Disease associations

CancerAutoimmunityChronic inflammationImmunodeficiency
05

Safety considerations

Immune-related adverse events (irAEs) due to excessive immune activation or blockade of inhibitory signals.Cytokine release syndrome
06

Interacting drugs

CTLA-4 inhibitors (e.g., Ipilimumab)

1 more in the full profile.

07

Biomarkers

CD80 expression levels on APCsCD86 expression levels on APCsCTLA-4 expression on T cells

Beyond the preview

Go deeper on B7 Proteins: CD80 (B7-1) and CD86 (B7-2) (B7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B7 Proteins: CD80 (B7-1) and CD86 (B7-2) (B7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call